Familial Mediterranean Fever (FMF) is the prototype of a group of inherited
inflammatory disorders. The gene (MEFV) responsible for this disease, comp
rises 10 exons and 781 codons. Twenty-nine mutations, most located in the l
ast exon, have been identified so far. It is unclear whether all are true d
isease-causing mutations. Five founder mutations, V726A, M694V, M6941, M680
1 and E148Q account for 74% of FMF chromosomes from typical cases (Armenian
s, Arabs, Jews, and Turks). Rare mutations are preferentially found in popu
lations not usually affected by FMF (eg Europeans not from the above ancest
ries). The various combinations of MEW mutations define severe to mild geno
types. The trend is that genotypes including two mutations located within m
utational 'hot-spots' (codons 680 or 694) of the gene are associated with s
evere phenotypes, whereas mild phenotypes are associated with some other mu
tations, E148Q being the mildest and least penetrant. Understanding the cor
relation between the FMF phenotype and genotype is further obscured by the
existence of complex alleles, modifier loci, genetic heterogeneity and poss
ible epigenetic factors. Additionally, mutations in the MEW gene are though
t to be involved in non FMF disorders. Carrier rates for FMF mutations may
be as high as 1:3 in some populations, suggesting that the disease is under
diagnosed. This review update emphasises that both clinical and genetic fea
tures are to be taken into account for patient diagnosis, colchicine treatm
ent and prognosis.